These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
299 related articles for article (PubMed ID: 24252780)
1. Evaluation of the in vitro activities of ceftobiprole and comparators in staphylococcal colony or microtitre plate biofilm assays. Abbanat D; Shang W; Amsler K; Santoro C; Baum E; Crespo-Carbone S; Lynch AS Int J Antimicrob Agents; 2014 Jan; 43(1):32-9. PubMed ID: 24252780 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of MBEC™-HTP biofilm model for studies of implant associated infections. Coraça-Hubér DC; Fille M; Hausdorfer J; Pfaller K; Nogler M J Orthop Res; 2012 Jul; 30(7):1176-80. PubMed ID: 22228044 [TBL] [Abstract][Full Text] [Related]
3. High in vitro antimicrobial activity of synthetic antimicrobial peptidomimetics against staphylococcal biofilms. Flemming K; Klingenberg C; Cavanagh JP; Sletteng M; Stensen W; Svendsen JS; Flaegstad T J Antimicrob Chemother; 2009 Jan; 63(1):136-45. PubMed ID: 19010828 [TBL] [Abstract][Full Text] [Related]
4. In vitro susceptibility to antibiotics of staphylococci in biofilms isolated from orthopaedic infections. Molina-Manso D; del Prado G; Ortiz-Pérez A; Manrubia-Cobo M; Gómez-Barrena E; Cordero-Ampuero J; Esteban J Int J Antimicrob Agents; 2013 Jun; 41(6):521-3. PubMed ID: 23611308 [TBL] [Abstract][Full Text] [Related]
5. Pharmacodynamic activity of ceftobiprole compared with vancomycin versus methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-intermediate Staphylococcus aureus (VISA) and vancomycin-resistant Staphylococcus aureus (VRSA) using an in vitro model. Zhanel GG; Voth D; Nichol K; Karlowsky JA; Noreddin AM; Hoban DJ J Antimicrob Chemother; 2009 Aug; 64(2):364-9. PubMed ID: 19454524 [TBL] [Abstract][Full Text] [Related]
6. Telavancin: in vitro activity against staphylococci in a biofilm model. Gander S; Kinnaird A; Finch R J Antimicrob Chemother; 2005 Aug; 56(2):337-43. PubMed ID: 15972312 [TBL] [Abstract][Full Text] [Related]
7. Effects of demethylfruticuline A and fruticuline A from Salvia corrugata Vahl. on biofilm production in vitro by multiresistant strains of Staphylococcus aureus, Staphylococcus epidermidis and Enterococcus faecalis. Schito AM; Piatti G; Stauder M; Bisio A; Giacomelli E; Romussi G; Pruzzo C Int J Antimicrob Agents; 2011 Feb; 37(2):129-34. PubMed ID: 21163629 [TBL] [Abstract][Full Text] [Related]
8. Impact of biofilm on the in vitro activity of vancomycin alone and in combination with tigecycline and rifampicin against Staphylococcus aureus. Rose WE; Poppens PT J Antimicrob Chemother; 2009 Mar; 63(3):485-8. PubMed ID: 19109338 [TBL] [Abstract][Full Text] [Related]
9. In vitro evaluation of the antibiotic lock technique (ALT) for the treatment of catheter-related infections caused by staphylococci. Lee JY; Ko KS; Peck KR; Oh WS; Song JH J Antimicrob Chemother; 2006 Jun; 57(6):1110-5. PubMed ID: 16556639 [TBL] [Abstract][Full Text] [Related]
10. Tolerant Small-colony Variants Form Prior to Resistance Within a Staphylococcus aureus Biofilm Based on Antibiotic Selective Pressure. Manasherob R; Mooney JA; Lowenberg DW; Bollyky PL; Amanatullah DF Clin Orthop Relat Res; 2021 Jul; 479(7):1471-1481. PubMed ID: 33835090 [TBL] [Abstract][Full Text] [Related]
11. Low-energy shock waves enhance the susceptibility of staphylococcal biofilms to antimicrobial agents in vitro. Wanner S; Gstöttner M; Meirer R; Hausdorfer J; Fille M; Stöckl B J Bone Joint Surg Br; 2011 Jun; 93(6):824-7. PubMed ID: 21586784 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of biofilm maturation by linezolid in meticillin-resistant Staphylococcus epidermidis clinical isolates: comparison with other drugs. Reiter KC; Villa B; Paim TGDS; de Oliveira CF; d'Azevedo PA J Med Microbiol; 2013 Mar; 62(Pt 3):394-399. PubMed ID: 23161766 [TBL] [Abstract][Full Text] [Related]
13. Inefficacy of vancomycin and teicoplanin in eradicating and killing Staphylococcus epidermidis biofilms in vitro. Claessens J; Roriz M; Merckx R; Baatsen P; Van Mellaert L; Van Eldere J Int J Antimicrob Agents; 2015 Apr; 45(4):368-75. PubMed ID: 25614358 [TBL] [Abstract][Full Text] [Related]
14. Antibacterial and anti-biofilm activities of thiazolidione derivatives against clinical staphylococcus strains. Liu H; Zhao Y; Zhao D; Gong T; Wu Y; Han H; Xu T; Peschel A; Han S; Qu D Emerg Microbes Infect; 2015 Jan; 4(1):e1. PubMed ID: 26038759 [TBL] [Abstract][Full Text] [Related]
15. Application of a feasible method for determination of biofilm antimicrobial susceptibility in staphylococci. Antunes AL; Trentin DS; Bonfanti JW; Pinto CC; Perez LR; Macedo AJ; Barth AL APMIS; 2010 Nov; 118(11):873-7. PubMed ID: 20955460 [TBL] [Abstract][Full Text] [Related]
16. [Susceptibility of Staphylococcus aureus biofilms to vancomycin, gemtamicin and rifampin]. Kotulová D; Slobodníková L Epidemiol Mikrobiol Imunol; 2010 Apr; 59(2):80-7. PubMed ID: 20586169 [TBL] [Abstract][Full Text] [Related]
17. Potency and penetration of telavancin in staphylococcal biofilms. Kirker KR; Fisher ST; James GA Int J Antimicrob Agents; 2015 Oct; 46(4):451-5. PubMed ID: 26213381 [TBL] [Abstract][Full Text] [Related]